uniQure NV (QURE)
6.055
+0.48
(+8.71%)
USD |
NASDAQ |
Nov 05, 16:00
6.055
0.00 (0.00%)
After-Hours: 18:21
uniQure Net Income (Quarterly): -56.30M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -56.30M |
| March 31, 2024 | -65.62M |
| December 31, 2023 | -73.21M |
| September 30, 2023 | -89.57M |
| June 30, 2023 | -68.47M |
| March 31, 2023 | -77.23M |
| December 31, 2022 | 6.807M |
| September 30, 2022 | -47.86M |
| June 30, 2022 | -39.06M |
| March 31, 2022 | -46.68M |
| December 31, 2021 | 8.208M |
| September 30, 2021 | -36.53M |
| June 30, 2021 | 399.47M |
| March 31, 2021 | -41.56M |
| December 31, 2020 | -0.699M |
| September 30, 2020 | -53.78M |
| June 30, 2020 | -42.55M |
| March 31, 2020 | -28.00M |
| December 31, 2019 | -41.43M |
| September 30, 2019 | -23.60M |
| June 30, 2019 | -31.40M |
| March 31, 2019 | -27.77M |
| December 31, 2018 | -21.89M |
| September 30, 2018 | -22.04M |
| Date | Value |
|---|---|
| June 30, 2018 | -20.59M |
| March 31, 2018 | -18.79M |
| December 31, 2017 | -27.47M |
| September 30, 2017 | -10.24M |
| June 30, 2017 | -21.27M |
| March 31, 2017 | -20.27M |
| December 31, 2016 | -14.72M |
| September 30, 2016 | -15.27M |
| June 30, 2016 | -21.08M |
| March 31, 2016 | -22.30M |
| December 31, 2015 | -17.53M |
| September 30, 2015 | -29.08M |
| June 30, 2015 | -21.18M |
| March 31, 2015 | -13.69M |
| December 31, 2014 | -16.94M |
| September 30, 2014 | -11.50M |
| June 30, 2014 | -12.26M |
| March 31, 2014 | -10.77M |
| December 31, 2013 | -10.04M |
| September 30, 2013 | -9.497M |
| June 30, 2013 | -10.13M |
| March 31, 2013 | -6.632M |
| December 31, 2012 | -6.078M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-89.57M
Minimum
Sep 2023
399.47M
Maximum
Jun 2021
-20.74M
Average
-42.55M
Median
Jun 2020
Net Income (Quarterly) Benchmarks
| ProQR Therapeutics NV | -2.899M |
| Merus NV | -99.90M |
| argenx SE | 91.41M |
| Pharming Group | -1.034M |
| Pharvaris NV | -32.01M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 11.13M |
| Total Expenses (Quarterly) | 55.14M |
| EPS Diluted (Quarterly) | -1.16 |
| Enterprise Value | -150.68M |
| Gross Profit Margin (Quarterly) | 32.94% |
| Profit Margin (Quarterly) | -506.0% |
| Earnings Yield | -97.94% |
| Normalized Earnings Yield | -97.39 |